Eversept Partners, LP Intra Cellular Therapies, Inc. Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

A detailed history of Eversept Partners, LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 124,491 shares of ITCI stock, worth $10.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
124,491
Holding current value
$10.4 Million
% of portfolio
0.72%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $8.46 Million - $10.1 Million
124,491 New
124,491 $9.1 Million
Q1 2023

Nov 08, 2023
BUY
$43.8 - $56.99 $9.58 Million - $12.5 Million
218,726 New
218,726 $11.8 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $9.58 Million - $12.5 Million
218,726 New
218,726 $11.8 Million
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $8.98 Million - $14.4 Million
-231,787 Closed
0 $0
Q4 2021

Nov 08, 2023
BUY
$35.2 - $53.42 $36,713 - $55,717
1,043 Added 0.45%
231,787 $12.1 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $36,713 - $55,717
1,043 Added 0.45%
231,787 $12.1 Million
Q3 2021

Nov 08, 2023
BUY
$28.72 - $42.49 $3.25 Million - $4.81 Million
113,282 Added 96.44%
230,744 $8.6 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $3.25 Million - $4.81 Million
113,282 Added 96.44%
230,744 $8.6 Million
Q2 2021

Nov 08, 2023
SELL
$29.3 - $44.5 $5.37 Million - $8.15 Million
-183,125 Reduced 60.92%
117,462 $4.79 Million
Q2 2021

Aug 16, 2021
SELL
$29.3 - $44.5 $5.37 Million - $8.15 Million
-183,125 Reduced 60.92%
117,462 $4.8 Million
Q1 2021

Nov 08, 2023
SELL
$30.8 - $39.51 $1.71 Million - $2.2 Million
-55,648 Reduced 15.62%
300,587 $10.2 Million
Q1 2021

May 13, 2021
SELL
$30.8 - $39.51 $1.71 Million - $2.2 Million
-55,648 Reduced 15.62%
300,587 $10.2 Million
Q4 2020

Nov 08, 2023
BUY
$23.34 - $32.22 $8.31 Million - $11.5 Million
356,235 New
356,235 $11.3 Million
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $4.19 Million - $5.78 Million
179,477 Added 101.54%
356,235 $11.3 Million
Q3 2020

Nov 08, 2023
BUY
$17.61 - $31.86 $3.11 Million - $5.63 Million
176,758 New
176,758 $4.54 Million
Q3 2020

Nov 13, 2020
BUY
$17.61 - $31.86 $3.11 Million - $5.63 Million
176,758 New
176,758 $4.54 Million

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email